West Pharmaceutical Services (WST) Free Cash Flow (2016 - 2025)
Historic Free Cash Flow for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $175.0 million.
- West Pharmaceutical Services' Free Cash Flow rose 10539.91% to $175.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $468.9 million, marking a year-over-year increase of 6964.54%. This contributed to the annual value of $468.9 million for FY2025, which is 6964.54% up from last year.
- West Pharmaceutical Services' Free Cash Flow amounted to $175.0 million in Q4 2025, which was up 10539.91% from $133.9 million recorded in Q3 2025.
- West Pharmaceutical Services' 5-year Free Cash Flow high stood at $175.0 million for Q4 2025, and its period low was $27.6 million during Q1 2024.
- Over the past 5 years, West Pharmaceutical Services' median Free Cash Flow value was $96.3 million (recorded in 2023), while the average stood at $96.5 million.
- Per our database at Business Quant, West Pharmaceutical Services' Free Cash Flow surged by 15117.65% in 2022 and then plummeted by 5071.43% in 2024.
- Over the past 5 years, West Pharmaceutical Services' Free Cash Flow (Quarter) stood at $84.3 million in 2021, then surged by 61.21% to $135.9 million in 2022, then dropped by 4.05% to $130.4 million in 2023, then tumbled by 34.66% to $85.2 million in 2024, then soared by 105.4% to $175.0 million in 2025.
- Its Free Cash Flow was $175.0 million in Q4 2025, compared to $133.9 million in Q3 2025 and $101.9 million in Q2 2025.